LITTLE FALLS, N.J.,
June 15, 2012 /PRNewswire/ --
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its
Board of Directors authorized a regular semiannual cash dividend of
$0.0467 per outstanding share of the
Company's Common Stock. The dividend is payable on July 31, 2012 to shareholders of record at the
close of business on July 17,
2012.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of
infection prevention and control products in the healthcare market.
Our products include water purification equipment, sterilants,
disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection
control products primarily for dental and GI endoscopy markets,
dialysate concentrates and other dialysis supplies, hollow fiber
membrane filtration and separation products for medical and
non-medical applications, and specialty packaging for infectious
and biological specimens. We also provide technical maintenance for
our products and offer compliance training services for the
transport of infectious and biological specimens. For further
information, visit the Cantel website at
http://www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.